Cambridge and London, UK: 11 November 2021

One Nucleus, the not-for-profit Life Science membership group focused primarily on the Greater Cambridge and London Life Sciences Cluster, aims to enable that ecosystem to accelerate the translation of great science and innovation into better patient outcomes. One Nucleus supports companies throughout their life cycle. This includes facilitating engagement between members and expert research partners and providers of key services and insight.

BioIVT, a leading provider of high-quality biological specimens and related services globally, recently expanded its national blood donor center in London, illustrating its commitment and ambition in the region. BioIVT has also become the latest company to join the One Nucleus Partner Programme, a programme tailor-made to meet the needs of the Partner, One Nucleus members and the sector.

Jeremy Clarke, Snr Director of Business Development at BioIVT, commented, “BioIVT brings an enormous depth of provision and expertise to the Life Sciences sector, covering the breadth of drug discovery across ADME-Tox and biological sample provision for R&D. We are pleased to be joining One Nucleus as a Partner which will enhance our engagement with the dynamic life sciences ecosystem in London, Cambridge and beyond, enabling us to support the vital translational research required by those companies to bring innovative treatments to patients.”

Tony Jones, CEO of One Nucleus expands further: “We are delighted to welcome BioIVT to the One Nucleus Partner Programme given the depth, scale and global reach it can bring to our members. Its portfolio of services, including the provision of biological samples via its London facility is unmatched and brings significant benefit to companies in the rapidly growing Advanced Therapeutics sector we are seeing emerge in the region.”